p75/AIRM1 and CD33, two sialoadhesin receptors that regulate the proliferation or the survival of normal and leukemic myeloid cells

Immunological Reviews

Volumn 181, Issue , 2001, Pages 260-268

  Mingari, Maria Cristina ^a,b   Vitale, Chiara ^b   Romagnani, Chiara ^b   Falco, Michela ^b,c   Moretta, Lorenzo ^b,c  

^a CENTRO DI BIOTECNOLOGIE AVANZATE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESION RECEPTOR MOLECULE 1; CD33 ANTIGEN; CELL PROTEIN; ETOPOFOS; LIGAND; PROTEIN P75; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; BONE MARROW CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC MYELOID LEUKEMIA; HUMAN; LEUKEMIA CELL; LEUKOCYTE FUNCTION; MACROPHAGE ACTIVATION; MONOCYTE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; REVIEW; SEQUENCE HOMOLOGY;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; APOPTOSIS; CELL DIVISION; CELL SURVIVAL; CROSS-LINKING REAGENTS; HEMATOPOIETIC STEM CELLS; HUMANS; KILLER CELLS, NATURAL; LEUKEMIA, MYELOID; RECEPTORS, IMMUNOLOGIC;

EID: 0034904570     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2001.1810122.x     Document Type: Review

References (39)

1. Biology of natural killer cells
2. In search of the "missing self". MHC molecules and NK cell recognition
3. Receptors for HLA-class I molecules in human natural killer cells
4. NK cell receptors
5. Regulation of immune responses through inhibitory receptors
6. Inhibitory pathways triggered by ITIM-containing receptors
7. NKp46, a novel natural killer cell-specific surface molecule which mediates cell activation
8. Molecular cloning of NKp46: A novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity
9. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells
10. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells is involved in non-MHC restricted tumor cell lysis
11. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily
12. Natural cytotoxicity receptors that trigger human NK-mediated cytolysis
13. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA
14. Role of NKG2D in tumor cell lysis mediated by human NK cells: Cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin
15. 2B4 functions as a co-receptor in human natural killer cell activation
16. Identification of NKp80 a novel triggering molecule expressed by human natural killer cells
17. Cytolytic T lymphocytes displaying natural killer (NK)-like activity. Expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production
18. + T lymphocyte subsets that express HLA class I- specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations
19. Regulation of KIR expression in human T lymphocytes. A safety mechanism which may impair protective T cell responses
20. Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family which functions as an inhibitory receptor in human natural killer cells
21. p40, a novel surface molecule involved in the regulation of the non-MHC restricted cytolytic activity in humans
22. LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes
23. Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human natural killer cells
24. Molecular cloning, expression, and chromosomal localization of a human gene encodong the CD33 myeloid differentiation antigen
25. Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction molecules
26. Murine and humanized constructs of monoclonal antibody M195 (anti-CD33) for the therapy of acute myelogenous leukemia
27. CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling
28. CD22 associates with the protein tyrosine phosphatase 1C, Syk, and phospholipase C-γ1 upon B cell activation
29. The myeloid-specific sialic acid binding receptor, CD33, associates with the protein-tyrosine phosphatases, SHP-1 and SHP-2
30. The sialoadhesin CD33 is a myeloid-specific inhibitory receptor
31. Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2
32. Growth and differentiation in the hemopoietic system
33. Structure of the gene encoding CD34, a human hematopoietic stem cell antigen
34. Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties
35. Engagement of p75/AIRM1 or CD33 inhibits the proliferation of normal or leukemic myeloid cells
36. Surface expression and function of p75/AIRM-1 or CD33 in acute myeloid leukemias. Engagement of CD33 induces apoptosis of leukemic cells
37. Interleukin-2 enhancement of cytotoxicity by humanized monoclonal antibody M195 (anti-CD33) in myelogenous leukemia
38. Supersaturating infusional humanized anti-CD33 monoclonal antibody HuM195 in myelogenous leukemia
39. + myeloid precursors